Before the conversation
What is on your mind? Start there. Use these questions for a visit in Boise or for telehealth, where care happens at a distance, including video visits.
The person
Ask for the person’s full name, job title and Idaho licence number.
Ask for a phone number or message address and who will answer if that person is unavailable.
As of September 2026, Idaho requires online care services to give you a way to contact the person treating you. That person or someone in the same medical practice must be available for care or questions after the visit.
The conversation
Make a note of current medicines, supplements, health conditions and the concern that brought you here.
Ask which tests or an in-person exam might be needed.
As of September 2026, Idaho does not accept treatment using just an online form with preset questions and answers.
That form can help prepare for a visit, but treatment must involve more than its answers.
Leave room for the person treating you to ask more questions, and for you to ask yours.
The medicine
Ask for the medicine’s name, then check its form: a shot, a tablet or something else.
In the US, the Food and Drug Administration (FDA) reviews medicines.
Ask whether the product has FDA approval or is compounded, meaning a pharmacy or doctor prepares it to order.
What benefit is realistic? What unwanted effects are possible with my health history?
Which pharmacy makes and sends it? How can I check that pharmacy’s licence?
If compounding comes up
Ask what an approved medicine cannot provide for your needs.
As of September 2026, semaglutide and tirzepatide shots do not appear on FDA’s national list of medicines in shortage.
A Boise pharmacy running out does not put a medicine on FDA’s national shortage list.
Being on that list can allow pharmacies to make copies of a medicine under federal rules.
Federal rules limit made-to-order copies when the approved medicine is available.
Ask: “Why is the pharmacy allowed to make this version for me?” Ask them to explain the reason in everyday words before you decide.
The whole bill
Ask for a written total: the visit or membership, medicine, tests and care after the visit.
As of September 2026, some online services charged a membership and billed the medicine separately.
As of September 2026, many drug-maker cash prices for approved weight and diabetes medicines were around $149–$499 a month.
That range is for the medicine alone. The price can change with the product, the amount in each shot or tablet, and the offer’s conditions.
Some offers give you a deadline for ordering the next supply; missing it can mean paying more. The amount sold as a month’s supply varies by product.
Ask: “When must I reorder to keep this price, and how many days will this supply last?”
Ask for the total cost of your visits and medicine once any starting discount ends.
With insurance, ask your plan whether it covers the medicine and needs approval before it will pay.
Ask who sends the request and how you will hear whether it was approved.
Medicare calls its temporary weight-medicine program the GLP-1 Bridge.
As of September 2026, eligible users pay $50 for a monthly supply through December 2027 under Medicare’s temporary GLP-1 Bridge.
Not everyone qualifies; you need a prescription and the Medicare Bridge program’s approval before getting its price.
Ask the person prescribing your medicine to request approval from the program. Confirm that it has been granted before counting on the $50 price.
Ask: “Do my health conditions and Medicare drug coverage qualify, and has the Bridge program approved my prescription?”
What is due if no prescription is written? Can I cancel a membership? What is the regular price when an offer runs out?